DR. ROBERT CALALUCE, MD
Osteopathic Medicine in Columbia, MO

License number
Missouri 106793
Category
Osteopathic Medicine
Type
General Practice
Address
Address 2
140 Walter Williams Hall, Columbia, MO 65211
1421 Kent Rd, Vandiver Village, MO 65265
Phone
(573) 882-4204
(573) 253-9581

Personal information

See more information about ROBERT CALALUCE at radaris.com
Name
Address
Phone
Robert Calaluce, age 70
1421 Kent Rd, Mexico, MO 65265
Robert Calaluce
Mexico, MO
(573) 581-4974
Robert Calaluce, age 70
1421 Kent Rd, Mexico, MO 65265
(573) 581-4974
Robert Calaluce
929 Jefferson St, Mexico, MO 65265
(573) 581-0632
Robert Calaluce
1421 Kent Rd, Mexico, MO 65265
(573) 581-4974

Professional information

See more information about ROBERT CALALUCE at trustoria.com
Robert Calaluce Photo 1
Modulating Levels Of Rna-Binding Proteins For The Treatment Of Breast Cancer

Modulating Levels Of Rna-Binding Proteins For The Treatment Of Breast Cancer

US Patent:
2011011, May 12, 2011
Filed:
Oct 8, 2010
Appl. No.:
12/924953
Inventors:
Ulus Atasoy - Columbia MO, US
Matthew Michael Gubin - Columbia MO, US
Robert Calaluce - Mexico MO, US
Assignee:
The Curators of the University of Missouri - Columbia MO
International Classification:
A61K 31/713, A61K 31/7088, A61K 35/76, A61P 35/00, A61P 35/04, C12N 5/09, C07H 21/00, C07H 21/04, C12N 15/63
US Classification:
424 936, 514 44 R, 514 44 A, 435375, 536 235, 4353201, 536 245
Abstract:
The present invention relates to methods of using RNA-binding protein modulating agents to treat of cancer, particularly patients that are susceptible to or diagnosed with estrogen receptor-negative breast cancer, such as methods of inhibiting the growth or metastasis of cancer cells comprising contacting cells with a therapeutically-effective amount of an HuR-modulating agent. The invention also relates to compositions comprising therapeutically-effective amounts of an HuR-modulating agent.


Robert Calaluce Photo 2
Dr. Robert Calaluce, Columbia MO - MD (Doctor of Medicine)

Dr. Robert Calaluce, Columbia MO - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
1 Hospital Dr, Columbia 65212
Languages:
English
Education:
Medical School
Medical College of Wisconsin
Graduated: 1990


Robert Calaluce Photo 3
Robert Calaluce - Mexico, MO

Robert Calaluce - Mexico, MO

Work:
MicroRNA Expression Levels and Their Relationship National Foundation For Cancer Research TLR Pathway Clinical Research - Tucson, AZ
Physician
NIH Clinical Research Loan Repayment Program Nutromix, LLC - Tucson, AZ
Vice President
NIH Clinical Research Loan Repayment Program Nancy and William Laurie Research Fund The Arizona Cancer Center College of American Pathologists Foundation - Aspen, CO Alpha Omega Alpha - Ann Arbor, MI University of Missouri School of Medicine Excellence in Education - Bethesda, MD
Medical Student Affairs Council
University of Missouri School of Medicine Medical College of Wisconsin
Summer Student Research Fellowship
Hartford Hospital - Hartford, CT
Phlebotomist
Hartford Hospital Aetna Life & Casualty - Hartford, CT
Copy Editor
Elm Hill Convalescent Home - Rocky Hill, CT
Freelance Writing, Substitute teaching
University of Connecticut
Education:
University of Missouri School of Medicine
Research Specialist
University of Arizona
Research Assistant Professor
University of Arizona - Tucson, AZ University of Missouri School of Medicine
pathology
University of Missouri School of Medicine - Columbia, MO Medical College of Wisconsin - Milwaukee, WI University of Connecticut - Storrs, CT
Doctor of Medicine in Premedical
Central Connecticut State University - New Britain, CT
Premedical Non
University of Connecticut - Storrs, CT
Master of Arts in English
Queens College of the City University of New York - Flushing, NY
Bachelor of Arts in English


Robert Calaluce Photo 4
Biomarkers And Method For Predicting Occurence Of Ventral Hernias

Biomarkers And Method For Predicting Occurence Of Ventral Hernias

US Patent:
2013029, Nov 7, 2013
Filed:
Mar 14, 2013
Appl. No.:
13/827472
Inventors:
Sharon L. Bachman - Columbia MO, US
Robert Calaluce - Columbia MO, US
Wade Davis - Columbia MO, US
Bruce J. Ramshaw - Columbia MO, US
International Classification:
A61F 2/00, C12Q 1/68
US Classification:
600 37, 506 9, 435 79, 506 17
Abstract:
Kits, methods of treating, and methods of diagnosing a risk level for an incisional hernia in a subject undergoing abdominal surgery are disclosed. They are designed to determine risk factors for incisional hernia formation based on a subject's unique gene expression profiles.


Robert Calaluce Photo 5
Hur-Associated Biomarkers

Hur-Associated Biomarkers

US Patent:
2011022, Sep 15, 2011
Filed:
Mar 11, 2011
Appl. No.:
13/046201
Inventors:
Ulus Atasoy - Columbia MO, US
Robert Calaluce - Columbia MO, US
Justin Wade Davis - Columbia MO, US
Assignee:
THE CURATORS OF THE UNIVERSITY OF MISSOURI - Columbia MO
International Classification:
G01N 33/573, C07K 14/47, C12N 9/14, C07H 21/02, G01N 33/68, G01N 33/53
US Classification:
435 74, 530350, 435195, 536 232, 536 245, 436501, 436 94
Abstract:
The present invention relates to methods of identifying gene targets, including methods of using ribonucleoprotein (RNP) immunoprecipitation-microarrays to identify cancer gene targets, such as subsets of RNP-associated mRNAs in breast cancer cell lines. Also presented, are ribonucleotide binding protein-associated biomarkers, panels or sets of ribonucleotide binding protein-associated biomarkers, methods and compositions comprising ribonucleotide-binding protein, associated nucleotides, nucleotide arrays, and kits to facilitate the diagnosis of and monitoring the disease status or progression of treatment of breast cancers, including drug-resistant breast cancers.